Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03304080
Title Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Beth Israel Comprehensive Cancer Center West New York New York 10011 United States Details
Perlmutter Cancer Center NYU Langone New York New York 10016 United States Details
Mount Sinai West New York New York 10019 United States Details
New York Presbyterian Columbia Irving Comprehensive Cancer Center New York New York 10032 United States Details
New York Presbyterian Weill Cornell Medical Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field